OACC (Oaktree Acquisition III Life Sciences) PB Ratio: 1.34 (As of Jun. 28, 2026)


OACC Oaktree Acquisition Corp III Life Sciences OACC
15 GF Score
Price $10.67
View Full Analysis

What is Oaktree Acquisition III Life Sciences PB Ratio?

Oaktree Acquisition III Life Sciences OACC -0.28% 15 PB Ratio is 1.34 as of Jun. 28, 2026. GuruFocus rates OACC with a GF Score™ of 15/100. Among 472 Diversified Financial Services companies, Oaktree Acquisition III Life Sciences ranks better than 56.78% on this metric.

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-28), Oaktree Acquisition III Life Sciences's share price is $10.67. Oaktree Acquisition III Life Sciences's Book Value per Share for the quarter that ended in Mar. 2026 was $7.98. Hence, Oaktree Acquisition III Life Sciences's PB Ratio of today is 1.34.

The historical rank and industry rank for Oaktree Acquisition III Life Sciences's PB Ratio or its related term are showing as below:

OACC' s PB Ratio Range Over the Past 10 Years
Min: 0   Med: 0   Max: 1.34
Current: 1.34

During the past 2 years, Oaktree Acquisition III Life Sciences's highest PB Ratio was 1.34. The lowest was 0.00. And the median was 0.00.

OACC's PB Ratio is ranked better than
56.78% of 472 companies
in the Diversified Financial Services industry
Industry Median: 1.385 vs OACC: 1.34

During the past 12 months, Oaktree Acquisition III Life Sciences's average Book Value Per Share Growth Rate was 3.90% per year.

Back to Basics: PB Ratio


Oaktree Acquisition III Life Sciences  (NAS:OACC) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Oaktree Acquisition III Life Sciences PB Ratio Related Terms


Oaktree Acquisition III Life Sciences PB Ratio Historical Data

* Premium members only.

The historical data trend for Oaktree Acquisition III Life Sciences's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oaktree Acquisition III Life Sciences PB Ratio Chart

Oaktree Acquisition III Life Sciences Annual Data
Trend Dec24 Dec25
PB Ratio
1.31 1.34

Oaktree Acquisition III Life Sciences Quarterly Data
Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
PB Ratio Get a 7-Day Free Trial 1.33 1.34 1.31 1.34 1.33

OACC vs RAAQ, FACT, PLMK: PB Ratio Comparison

For the Shell Companies subindustry, Oaktree Acquisition III Life Sciences's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oaktree Acquisition III Life Sciences PB Ratio vs Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Oaktree Acquisition III Life Sciences's PB Ratio distribution charts can be found below:

* The bar in red indicates where Oaktree Acquisition III Life Sciences's PB Ratio falls into.


OACC
15GF Score
Oaktree Acquisition Corp III Life Sciences OACC
PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Oaktree Acquisition III Life Sciences PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Oaktree Acquisition III Life Sciences's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2026)
=10.67/7.981
=1.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Frequently Asked Questions Learn more about PB Ratio →
What does a PB Ratio of 1.34 mean?
Oaktree Acquisition III Life Sciences (OACC) has a PB Ratio of 1.34 as of Jun. 28, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Oaktree Acquisition III Life Sciences and its competitors. According to the industry distribution chart, Oaktree Acquisition III Life Sciences ranks #204 out of 472 companies in the Diversified Financial Services industry, placing it in the top 43.2%.
Is Oaktree Acquisition III Life Sciences' PB Ratio too high?
Oaktree Acquisition III Life Sciences' current PB Ratio is 1.34. The Diversified Financial Services industry median PB Ratio is 1.39. Oaktree Acquisition III Life Sciences' value of 1.34 is 3.2% below this industry median. Based on the distribution chart, Oaktree Acquisition III Life Sciences ranks #204 out of 472 companies in the Diversified Financial Services industry, which is above the industry midpoint. Overall, Oaktree Acquisition III Life Sciences has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Oaktree Acquisition III Life Sciences' PB Ratio compare to RAAQ and FACT?
According to the Diversified Financial Services industry distribution chart, Oaktree Acquisition III Life Sciences ranks #204 out of 472 companies for PB Ratio. This puts Oaktree Acquisition III Life Sciences in the upper half of its industry. The industry median PB Ratio is 1.39. Oaktree Acquisition III Life Sciences' value of 1.34 is 3.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Diversified Financial Services company?
The median PB Ratio among Diversified Financial Services companies is 1.39, based on 472 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Oaktree Acquisition III Life Sciences's current PB Ratio of 1.34 is 3.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Oaktree Acquisition III Life Sciences and its competitors. For the Diversified Financial Services industry, the median PB Ratio is 1.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Oaktree Acquisition III Life Sciences's current PB Ratio is 1.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oaktree Acquisition III Life Sciences stock overvalued right now?
Oaktree Acquisition III Life Sciences (OACC) has a current PB Ratio of 1.34. The current PB Ratio is 1.34 and 3.2% below the Diversified Financial Services industry median of 1.39. Oaktree Acquisition III Life Sciences' overall GF Score™ is 15/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Oaktree Acquisition III Life Sciences (OACC), the current PB Ratio is 1.34 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Oaktree Acquisition III Life Sciences Business Description

Address 333 South Grand Avenue, 28th Floor, Los Angeles, CA, USA, 90071
Oaktree Acquisition Corp III Life Sciences is a blank check company.
15GF Score

Get the complete analysis for OACC

PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.67
Price